Background
The history of organoids
Establishment of cancer organoids
Function | |
---|---|
Growth factors | |
EGF | ◆ A well-known growth factor for epithelial tissues; ◆ EGF, binding to EGF receptors, induces hyperplasic changes; ◆ EGF promotes tumor growth through stimulating the proliferation of cancer cells. |
FGF10 | ◆ FGF10/FGF receptor 2IIIb axis is important for the organ development, including the stomach, liver, breast, and prostate; ◆ FGF10 promotes migration and invasion of pancreatic cancer cells and drives tumorigenesis of breast cancer; |
FGF7 | ◆ FGF7/FGF receptor 2 signaling promotes growth, invasion, and migration of tumors. |
HGF | ◆ HGF/Met signaling promoted oncogenesis, tumor angiogenesis, tumor invasion of multiple tumor types; |
Wnt | ◆ A master regulator in regulation of cell development, proliferation, differentiation, adhesion, and polarity; ◆ The aberrant activation of Wnt signaling promotes carcinogenesis and progression of cancers. |
Noggin | ◆ An inhibitor of bone morphogenetic proteins that modulates cellular differentiation, proliferation, and apoptosis; ◆ Noggin promotes bone metastasis of some cancers and is associated with tumorigenesis of primary bone malignancies. |
R-spondin-1 | ◆ The ligand of Lgr5 and a niche factor that is required for the self-renewal of stem cells and activates Wnt signaling; ◆ R-spondin-1facilitates the growth and metastasis of cancer cells. |
Gastrin | ◆ Gastrin stimulates tumor growth through promoting the proliferation and suppressing the apoptosis of cancer cells; |
Prostaglandin E2 | ◆ Prostaglandin E2 promotes angiogenesis in gastric cancer through the up-regulation of vascular endothelial growth factor. |
Nicotinamide | ◆ Vitamin PP is a nutrient that is required for long-term culture of organoids. |
Neuregulin 1 | ◆ It is a ligand of human EGF receptor tyrosine kinases-3 and -4; ◆ It is involved in mammary development and tumorigenesis. |
Molecule inhibitors | |
Y27632 | ◆ A Rho kinase inhibitor that effectively reduces the anoikis of dissociated stem cells; ◆ Y27632 improves culture media and promotes proliferation of tumor epithelial cells for long-term in vitro; |
A-83-01 | ◆ A transforming growth factor-beta inhibitor; ◆ Transforming growth factor-beta inhibitor suppresses the proliferation of organoids; |
SB202190 | ◆ It is a p38 inhibitor and suppresses the proliferation and migration of cancer cells; ◆ High concentration of SB202190 contributes to relatively lower efficiency of the establishment of breast tumoroids. |
Tumoroid type | Culture components | Ref | ||
---|---|---|---|---|
Extracellular matrix | Growth factors | Molecule inhibitors | ||
Stomach cancer | Matrigel (growth factor reduced) | ADMEM/F12, penicillin/streptomycin, L-glutamine, B27, N2, bovine serum albumin, EGF, Noggin, R-spondin-1, gastrin, FGF10, FGF-basic, Wnt3A, prostaglandin E2, and nicotinamide | A-83-01 Y27632 SB202190 | [26] |
Intestinal cancer | ||||
Liver cancer | Basement membrane extract | Classical human liver organoid isolation medium: ADMEM/F12, penicillin/streptomycin, GlutaMAX, HEPES, B27 (without vitamin A), N2, N-acetylcysteine, nicotinamide, gastrin 1, EGF, FGF10, HGF, forskolin, R-spondin-1, Wnt3A, and Noggin Tumoroid-specific isolation medium: Classical human liver organoid isolation medium with the elimination of R-spondin-1, Wnt3A, and Noggin as well as addition of dexamethasone Human healthy liver-derived organoids expansion medium Classical human liver organoid isolation medium with the elimination of Y27632, Wnt3A, and Noggin | A-83-01 Y27632 | [34] |
Pancreatic cancer | Matrigel | ADMEM/F12, penicillin/streptomycin, GlutaMAX, HEPES, B27, N-acetylcysteine, EGF, R-spondin-1, gastrin 1, Wnt3A, Noggin, and FGF | A-83-01 | [66] |
Breast cancer | Basement membrane extract (reduced growth factor) | ADMEM/F12, penicillin/streptomycin, GlutaMAX, HEPES, B27, N-acetylcysteine, R-spondin-1, FGF7, FGF10, nicotinamide, Noggin, primocin, and neuregulin 1 | A-83-01 Y27632 | [38] |
Bladder cancer | Matrigel | Hepatocyte media with EGF, FBS, GlutaMAX, and primocin | Y27632 | [67] |
Prostate cancer | Matrigel (growth factor reduced) | ADMEM, penicillin/streptomycin, primocin, GlutaMAX, B27, EGF, N-acetylcysteine, FGF10, FGF-basic, nicotinamide, testosterone, prostaglandin E2, Noggin, and R-spondin | A-83-01 SB202190 | [68] |